Hampton S M, Kwasowski P, Tan K, Morgan L M, Marks V
Diabetologia. 1983 Apr;24(4):278-81. doi: 10.1007/BF00282713.
Male Wistar rats were pretreated with 3 ml triolein orally for 4 days in addition to their normal diet. A similar control group were allowed free access to normal laboratory food. When given an oral fat load (1 ml triolein) plasma gastric inhibitory polypeptide (GIP) and triglyceride levels were significantly higher in the fat pretreated group. Inhibition of fat-stimulated GIP release by exogenous insulin was demonstrated in the untreated control group (plasma GIP: 663 +/- 49 versus 853 +/- 92 ng/l, mean +/- SEM p less than 0.025), but pretreatment with an oral fat load abolished this effect (plasma GIP: 1008 +/- 95 versus 1116 +/- 100 ng/l, p NS). Plasma glucose levels were significantly higher in fat pretreated rats given oral fat and intraperitoneal insulin compared with untreated controls (plasma glucose nadir 2.6 +/- 0.48 versus 1.6 +/- 0.15 mmol/l, p less than 0.05). Fat-pretreated rats showed significantly higher insulin and glucose levels compared with the untreated rats when given oral glucose (plasma insulin: 6.2 +/- 1.2 versus 2.5 +/- 0.59 micrograms/l, p less than 0.01; plasma glucose: 10.2 +/- 0.39 versus 8.9 +/- 0.41 mmol/l, p less than 0.025). Pretreatment of rats on a high fat diet causes (1) increased GIP secretion in response to an oral fat load, (2) abolition of the feed-back inhibition of exogenous insulin on fat-stimulated GIP release, and (3) some degree of insulin resistance.
雄性Wistar大鼠除正常饮食外,口服3毫升三油酸甘油酯,持续4天。给予相似的对照组正常实验室食物自由摄取。给予口服脂肪负荷(1毫升三油酸甘油酯)后,脂肪预处理组的血浆胃抑制性多肽(GIP)和甘油三酯水平显著更高。在未处理的对照组中,外源性胰岛素可抑制脂肪刺激的GIP释放(血浆GIP:663±49对853±92纳克/升,均值±标准误,p<0.025),但口服脂肪负荷预处理消除了这种作用(血浆GIP:1008±95对1116±100纳克/升,p无显著性差异)。与未处理的对照组相比,给予口服脂肪和腹腔注射胰岛素后,脂肪预处理大鼠的血浆葡萄糖水平显著更高(血浆葡萄糖最低点:2.6±0.48对1.6±0.15毫摩尔/升,p<0.05)。给予口服葡萄糖时,与未处理的大鼠相比,脂肪预处理大鼠的胰岛素和葡萄糖水平显著更高(血浆胰岛素:6.2±1.2对2.5±0.59微克/升,p<0.01;血浆葡萄糖:10.2±0.39对8.9±0.41毫摩尔/升,p<0.025)。高脂饮食大鼠的预处理导致:(1)对口服脂肪负荷的反应中GIP分泌增加;(2)外源性胰岛素对脂肪刺激的GIP释放的反馈抑制作用消除;(3)某种程度的胰岛素抵抗。